Recent News

• 11.07.2024 - Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024
• 11.01.2024 - Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q

Recent Filings

• 02.07.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.06.2025 - EFFECT Notice of Effectiveness
• 02.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.31.2025 - 8-K Current report
• 01.29.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 01.14.2025 - EX-99.1 EX-99.1
• 11.18.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.13.2024 - NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB